Collateral Therapeutics,Inc. (CLTX)

Article Abstract:

The operations and management of Collateral Therapeutics Inc of San Diego, CA, are discussed in detail by president, CFO, and COO Christopher J. Reinhard. Cardiovascular gene therapy is the company's main focus.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Introgen Therapeutics, Inc. (INGN)

Article Abstract:

The operations and management of Intogen Therapeutics Inc of Austin, TX, are discussed in detail by president and CEO David G. Nance. Gene therapy products for cancer treatment is the company's major focus.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Restoragen, Inc

Article Abstract:

The operations and management of Resoragen Inc of Lincoln, NE, are discussed in detail by chairman and CEO Thomas R. Coolidge. The company provides peptide hormone therapies for a wide variety of diseases.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: